Septin 9 methylated DNA is a sensitive and specific blood test for colorectal cancer

References

Page 1

	Year	Citations
Two-sided confidence intervals for the single proportion: comparison of seven methods Robert G. Newcombe Statistics in Medicine	1998	5K
Prevention of Colorectal Cancer by Colonoscopic Polypectomy Sidney J. Winawer, Ann G. Zauber, May Nah Ho, New England Journal of Medicine	1993	4.6K
Probable Inference, the Law of Succession, and Statistical Inference Edwin B. Wilson Journal of the American Statistical Association American Statistical AssociationEngineeringInductive InferenceImprecise ProbabilityStatistical Foundation	1927	3.5K
Randomised controlled trial of faecal-occult-blood screening for colorectal cancer J D Hardcastle, J Chamberlain, Michael HE Robinson, The Lancet Cancer ScreeningMedicinePathologyColorectal CancerOncology	1996	2.8K
Randomised study of screening for colorectal cancer with faecal-occult-blood test O Kronbörg, Claus Fenger, Jørn Olsen, The Lancet Cancer DetectionCancer ScreeningMedicineDiagnosisPathology	1996	2.5K
Free DNA in the serum of cancer patients and the effect of therapy. Shalom A. Leon, B Shapiro, D.M. Sklaroff, PubMed Dna ConceneCancer PathologyMalignant DiseaseOncogenic AgentLupus	1977	1.8K
A Case–Control Study of Screening Sigmoidoscopy and Mortality from Colorectal Cancer Joe V. Selby, Gary Friedman, Charles P. Quesenberry, New England Journal of Medicine	1992	1.7K
Screening Sigmoidoscopy and Colorectal Cancer Mortality PA Newcomb, Robert G. Norfleet, Barry E. Storer, JNCI Journal of the National Cancer Institute	1992	923
Colorectal Cancer Mortality: Effectiveness of Biennial Screening for Fecal Occult Blood Jeffrey S. Mandel, Timothy R. Church, Fred Ederer, JNCI Journal of the National Cancer Institute	1999	788
Patterns of Colorectal Cancer Screening Uptake among Men and Women in the United States Helen I. Meissner, Nancy Breen, Carrie N. Klabunde, Cancer Epidemiology Biomarkers & Prevention	2006	570

Page 1